EUVIMEDEUVIMED entdecken
Kohortenstudie

Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021

Michael H Le, Joanne K Liu, KeeSeok Lee, Ramsey Cheung, Mindie H Nguyen iD

Alimentary Pharmacology & Therapeutics · 2025-08 · 62 (3) · 340-348

DOI: 10.1111/apt.70193 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 26.05.2025. Verfasst von Michael H Le und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Delayed Diagnosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Underdiagnosis of chronic hepatitis B (CHB) remains a major problem in the United States (USA), with > 80% of CHB patients remaining undiagnosed.

Aims

To determine the prevalence of late diagnosis of CHB and resultant liver complications.

Methods

This retrospective analysis of the Truven MarketScan database (1/2007–12/2021) included more than 250 million privately insured persons. The index date was the date of the first liver complication (cirrhosis, hepatocellular carcinoma [HCC], or liver transplant). Late diagnosis was defined as the diagnosis of CHB 2 years prior to or after the index date. Adults aged ≥ 18 years with a diagnosis of CHB and ≥ 12 months of insurance coverage prior to the index date were included. Exclusion criteria included > 90 days break of insurance coverage within 12 months before the index date and receipt of nonliver transplant within 5 years of the index date.

Results

2608 persons met inclusion criteria with a mean age of 54.8 years and 70.3% were male. 1999 (76.6%) had a late diagnosis of CHB, of whom 889 (44.5%) were diagnosed at or within 6 months of the index complication, and 1510 (75.5%) did not have a documented visit with a provider to the index date. Late diagnosis rate remained stable between 2009 (73.8%) and 2017 (74.2%, p‐trend = 0.937 ) . In the late diagnosis group, complications included cirrhosis ( n = 1820, 91.0%), decompensated cirrhosis ( n = 1630, 81.5%), HCC ( n = 615, 30.8%) and liver transplant ( n = 288, 14.4%).

Conclusion

Approximately three‐fourths of patients diagnosed with CHB in the USA had a late diagnosis. Increased screening efforts must be made to prevent poor clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicDelayed DiagnosisHumansMaleFemaleRetrospective StudiesMiddle AgedUnited StatesAdultAgedCarcinoma, HepatocellularLiver NeoplasmsPrevalenceCohort StudiesYoung AdultLiver Cirrhosis

Stichwörter der Autor:innen

diagnosishepatitis Bpericomplicationscreening

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.
  • The Robert Larner MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
  • Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System, Palo Alto, California, USA.
  • Department of Epidemiology and Population Health, Stanford School of Medicine, Stanford, California, USA.

ORCID-Profile: Mindie H Nguyen

Zitieren

APA

Le, M. H., Liu, J. K., Lee, K., Cheung, R., & Nguyen, M. H. (2025). Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021. Alimentary Pharmacology & Therapeutics, 62(3), 340-348. https://doi.org/10.1111/apt.70193

Vancouver

Le MH, Liu JK, Lee K, Cheung R, Nguyen MH. Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021. Alimentary Pharmacology & Therapeutics. 2025;62(3):340-348. doi:10.1111/apt.70193

BibTeX
@article{Le2025,
  author = {Le, Michael H and Liu, Joanne K and Lee, KeeSeok and Cheung, Ramsey and Nguyen, Mindie H},
  title = {Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {62},
  number = {3},
  pages = {340--348},
  doi = {10.1111/apt.70193}
}
Kostenlos starten →